Decoding the Nexus: Cellular and Molecular Mechanisms Linking Stroke and Neurotoxic Microenvironments in Brain Cancer...

Area of Science:

• Neuroscience
• Oncology
• Vascular Biology

Background:

• Stroke is a major complication in brain cancer patients.
• The interplay between cancer and cerebrovascular health elevates stroke risk.
• The neurotoxic microenvironment (NTME) is a key factor.

Purpose of the Study:

• To review the multifactorial pathophysiology linking brain cancer to stroke risk.
• To emphasize the role of the NTME in stroke development.
• To explore novel therapeutic strategies targeting the NTME.

Main Methods:

• Review of existing literature on brain cancer and stroke.
• Analysis of pathophysiological mechanisms including NTME, hypercoagulability, and inflammation.
• Exploration of genomic and proteomic biomarkers for stroke susceptibility.

Main Results:

• The NTME, characterized by oxidative stress, neuroinflammation, and BBB disruption, promotes vascular and neuronal injury.
• Cancer-related hypercoagulability, inflammation, and tumor-associated processes contribute to stroke.
• Genomic/proteomic profiling offers potential for personalized medicine and biomarker identification.

Conclusions:

• Targeting the NTME with antioxidants, anti-inflammatory agents, and BBB-reinforcing therapies shows promise for stroke prevention.
• An integrative approach can reduce stroke incidence and severity in brain cancer patients.
• Further research and clinical trials are needed to validate and implement these strategies.